CAREFUSION SD

Manufacturer adverse-event records for CAREFUSION SD come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2014–2026 · heavy-book · quiet Death-code · injury-light

Volume signature

CAREFUSION SD sits in the heavy MAUDE book

CAREFUSION SD accounts for 1,368,264 FDA MAUDE reports (#3 of 443, heavy-book tercile). Death-coded event_type share is 0.01% (quiet); Injury share 0.1% (injury-light).

What the volume reading shows for CAREFUSION SD

The standout signal for CAREFUSION SD is filing volume: 1,368,264 adverse-event reports in FDA MAUDE (#3 of 443, heavy-book). Death-coded event_type share sits at 0.01% (quiet).

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair CAREFUSION SD with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 11 device types, led in this extract by Malfunction at 1,366,934 (99.9% of event_type total). Peak single-year volume reaches 871,325 reports across 13 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

1,368,264
Total Reports
183
Event-type Death
1,147
Injury Reports
11
Device Types

Event Types

Malfunction 1,366,934 (99.9%)
Injury 1,147 (0.1%)
Death 183 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

1,364,009 (99.8%)
Other 1,343 (0.1%)
Required Intervention 1,038 (0.1%)
Death 196 (0.0%)
R 46 (0.0%)
Life Threatening 25 (0.0%)
Hospitalization 19 (0.0%)
O 13 (0.0%)
Disability 10 (0.0%)
Congenital Anomaly 9 (0.0%)
D 6 (0.0%)
L 3 (0.0%)
H 2 (0.0%)
S 2 (0.0%)

Yearly Trend

14
2014: 3
15
2015: 21
16
2016: 27
17
2017: 22
18
2018: 78
19
2019: 52
20
2020: 78,464
21
2021: 188,239
22
2022: 871,325
23
2023: 154,734
24
2024: 37,088
25
2025: 33,187
26
2026: 5,024